apicdmo-logoapicdmo-logoapicdmo-logo-mobileapicdmo-logo-mobile
  • Home
  • Blog
  • Our products
    • Favipiravir
      • Favipiravir(259793-96-9)
      • 3,6-dichloropyrazine-2-carbonitrile
      • 6-bromo-3-hydroxypyrazine-2-carboxamide
  • About us
  • Our services
  • Contact

  • Home
  • Favipiravir
  • Favipiravir(259793-96-9)
356783-16-9
3,6-dichloropyrazine-2-carbonitrile
July 3, 2020
259793-96-9

Favipiravir(259793-96-9)

Favipiravir, also called T 705,which is a pyrazinecarboxamide derivative with activity against RNA viruses. Favipiravir is converted to the ribofuranosyltriphosphate derivative by host enzymes and selectively inhibits the influenza viral RNA-dependent RNA polymerase.On the base of Favipiravir mechanism, It often treat influenza in Japan and it was also being studied to treat a number of other viral infections.Especially for coronavirus(COVID-2019), Favipiravir was approved for treatment of COVID-2019 by China, Japan, Russia,Korea, India…. After several clinical trials at different countries, this drug has shown very positive results.

Category: Favipiravir
Share
0
  • Description

Favipiravir(259793-96-9) Information

Product Favipiravir
CAS No. 259793-96-9
Synonyms T705

6-fluoro-3-hydroxypyrazine-2-carboxamide

6-fluoro-3-hydroxy-2-carboxamide

Availability In Stock
MF. C5H4FN3O2 MW. 157.1025632
Appearance Yellowish to off – white crystalline powder Purity 98%
Application  

For research use only

Storage RT
COA & NMR Download MSDS Download
[Reference]

[1] Koons C (7 August 2014). “Ebola Drug From Japan May Emerge Among Key Candidates”. Bloomberg.com.

[2] Fink S (4 February 2015). “Ebola Drug Aids Some in a Study in West Africa”. The New York Times.

[3] Lumby, Casper (3 March 2020). “Favipiravir and Zanamivir Cleared Infection with Influenza B in a Severely Immunocompromised Child”. Clinical Infectious Diseases. Retrieved 5 May 2020.

[4] EJ Lane (June 22, 2016). “Fujifilm in Avigan API license with Zhejiang Hisun Pharmaceuticals”. Fierce Pharma. Retrieved April 20, 2020.

[5]”Medicine registration license ЛП-006225″. Government registry of medicines. Russian Ministry of Health. Retrieved May 30, 2020.

[6] Favipiravir

 

Related products

  • 356783-16-9

    3,6-dichloropyrazine-2-carbonitrile

  • 259793-88-9

    6-bromo-3-hydroxypyrazine-2-carboxamide

FEEL FREE TO CONTACT US

+86(1368)2461609

[email protected]


www.wisepowder.com www.scienceherb.com
www.cofttek.com www.phcoker.com
www.aasraw.com www.apicmo.com www.cmoapi.com

Useful links

Home
Blog
Our Products
Contact us
About us
Our Service
Apicdmo Scholarship

ADDRESS

JINAN APICDMO BIOTECHNOLOGY CO., LIMITED


No.27-2 Keyuan Street, Economic Development District,Shanghe County, Jinan City, Shandong Province

© 2020 apicdmo.com. All Rights Reserved. Disclaimer: We do not make any claims about the products sold on this website. No information provided on this website has been evaluated by the FDA or MHRA. Any information provided on this website is provided to the best of our knowledge and is not intended to replace the advice of a qualified medical practitioner. Any testimonials or product reviews provided by our customers are not the views of apicdmo.com and should not be taken as recommendation or fact.
  • Terms and conditions
  • Privacy policy
  • apicdmo